Cargando…

Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia

Valvular heart disease frequently occurs as a consequence of premature atherosclerosis in individuals with familial hypercholesterolemia (FH). Studies have primarily focused on aortic valve calcification in heterozygous FH, but there is paucity of data on the incidence of valvular disease in homozyg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fahed, Akl C., Shibbani, Kamel, Andary, Rabih R., Arabi, Mariam T., Habib, Robert H., Nguyen, Denis D., Haddad, Fady F., Moubarak, Elie, Nemer, Georges, Azar, Sami T., Bitar, Fadi F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518507/ https://www.ncbi.nlm.nih.gov/pubmed/28761763 http://dx.doi.org/10.1155/2017/3685265

Ejemplares similares

Variable expressivity and co‐occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy
por: Fahed, Akl C., et al.
Publicado: (2016)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
por: Fahed, Akl C., et al.
Publicado: (2012)

A Novel Mutation in FOXC1 in a Lebanese Family with Congenital Heart Disease and Anterior Segment Dysgenesis: Potential Roles for NFATC1 and DPT in the Phenotypic Variations
por: Khalil, Athar, et al.
Publicado: (2017)

A Novel Role for CSRP1 in a Lebanese Family with Congenital Cardiac Defects
por: Kamar, Amina, et al.
Publicado: (2017)

Surgical treatment of valvular and supravalvular aortic stenosis in homozygous familial hypercholesterolemia
por: Sato, Hisashi, et al.
Publicado: (2014)

Two Heterozygous Mutations in NFATC1 in a Patient with Tricuspid Atresia
por: Abdul-Sater, Zahi, et al.
Publicado: (2012)

Novel EIF2AK4 mutations in histologically proven pulmonary capillary hemangiomatosis and hereditary pulmonary arterial hypertension
por: Abou Hassan, Ossama K., et al.
Publicado: (2019)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

NKX2-5 Mutations in an Inbred Consanguineous Population: Genetic and Phenotypic Diversity
por: Abou Hassan, Ossama K., et al.
Publicado: (2015)

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2015)

Homozygous familial hypercholesterolemia with an update on cholesterol management
por: Velvet, Anju J J, et al.
Publicado: (2020)

Xanthoma tuberosum in homozygous familial hypercholesterolemia
por: Moorthy, Nagaraja, et al.
Publicado: (2014)

Liver Transplantation for Homozygous Familial Hypercholesterolemia
por: Ishigaki, Yasushi, et al.
Publicado: (2019)

Treatment of Homozygous Familial Hypercholesterolemia With Evinacumab
por: Jeraj, Natasha, et al.
Publicado: (2021)

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
por: Bajaj, Archna, et al.
Publicado: (2022)

GATA5 mutation homozygosity linked to a double outlet right ventricle phenotype in a Lebanese patient
por: Kassab, Kameel, et al.
Publicado: (2015)

Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl
por: Ekici, Filiz, et al.
Publicado: (2018)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

New algorithms for treating homozygous familial hypercholesterolemia
por: Tromp, Tycho R., et al.
Publicado: (2022)

Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
por: Fahed, Akl C., et al.
Publicado: (2020)

A Case of Premature Triple Vessel Coronary Artery Disease and Valvular Degeneration: A Rare Presentation of Familial Hypercholesterolemia
por: Gull, Rukham, et al.
Publicado: (2020)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
por: Derenbecker, Robert, et al.
Publicado: (2019)

Homozygous Familial Hypercholesterolemia: Case Series and Review of the Literature
por: Palacio, Carlos H., et al.
Publicado: (2011)

Homozygous Familial Hypercholesterolemia Associated with Symmetric Subcutaneous Lipomatosis
por: Dawoud, Noha Mohammed, et al.
Publicado: (2015)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
por: Walzer, S, et al.
Publicado: (2013)

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2017)

Evidence-Based, Mechanistic Approach to the Management of Homozygous Familial Hypercholesterolemia
por: Rosenson, Robert S.
Publicado: (2022)

Homozygous Familial Hypercholesterolemia: Luck Meets Opportunity Meets Knowledge
por: Young, Lisa, et al.
Publicado: (2022)

Treatment of Homozygous Familial Hypercholesterolemia With ANGPTL3 Inhibitor, Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia
por: Singhania, Pankaj, et al.
Publicado: (2022)

Redux valvular surgery with coronary artery bypass graft in familial hypercholesterolemia
por: Jalel, Ziadi, et al.
Publicado: (2014)

Successful Treatment of Homozygous Familial Hypercholesterolemia Using Cascade Filtration Plasmapheresis
por: Kardaş1, Fatih, et al.
Publicado: (2012)

SUN-070 Asymptomatic Patients with Homozygous Familial Hypercholesterolemia: A Challenge
por: Lam, Cesar, et al.
Publicado: (2019)

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
por: Huang, Chin-Chou, et al.
Publicado: (2019)

Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis
por: Wong, Karen H.Y., et al.
Publicado: (2019)

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
por: Pu, Xia, et al.
Publicado: (2021)

Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fqoe0pndkge2kuolbjvbsmc0m3